跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,449 条关于
“FibroSpect NASH”
全部
1,449
临床试验
972
药物
35
机构
10
资讯
432
4个月前
Prometheus Laboratories Advances Next-Generation Blood Test for MASH Patient Identification
去年
Resmetirom Shows Promise in Treating MASLD/MASH: A Comprehensive Review of Clinical Trials
去年
Semaglutide Shows Superior Efficacy Over Rezdiffra in NASH Resolution and Fibrosis Reduction
去年
Morepen Laboratories Advances Development of Resmetirom for NASH Treatment
去年
NASH Treatment Market to Reach Significant Growth by 2032, Driven by Emerging Therapies
去年
NASH Pipeline Shows Promise with 80+ Emerging Therapies in Development
去年
Madrigal's Resmetirom Shows Promise in NASH Treatment Where Others Have Failed
6年前
FDA Rejects Intercept's NASH Drug Obeticholic Acid, Raising Industry-Wide Concerns
去年
Madrigal Pharmaceuticals Advances in NASH Treatment with Resmetirom Phase 3 Trials
6个月前
Vimgreen's A2A Receptor Antagonist VG081821 Receives First Global IND Approval for NASH Treatment
第 1 页,共 44 页
上一页
下一页